No Data
No Data
Opyl Ltd. Advises Investor Caution and Diligence
Opyl Ltd Announces Director's Final Interests
Opyl Ltd. Advances AI Platform and Streamlines Business
Opyl Ltd. Calls for Virtual General Meeting
Opyl Expands TrialKey Coverage; Shares Up 38%
Digital health company Opyl (ASX:OPL) expanded its TrialKey.ai platform, increasing its coverage to 350,000 trials from 65,000 and enhancing its ability to predict and optimize clinical research and d
Opyl to Divest Opin Business
Opyl (ASX:OPL) signed a binding sale and purchase agreement to divest its Opin business, allowing the company to focus on high-growth, artificial intelligence-related ventures, according to a Tuesday
No Data